Argentiere Capital’s Bausch Health BHC Stock Holding History

Argentiere Capital’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-16,200	Closed	-$326K	–	52
2016 Q2	$326K	Buy	+16,200	New	+$459K	0.25%	45

Other funds holding BHC

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Argentiere Capital's BHC Position: Q3 2016 in Review

Argentiere Capital sold out of Bausch Health (BHC) in Q3 2016, closing a stake of 16,200 shares — an estimated $326K sold.

Argentiere Capital first reported a position in BHC in Q2 2016 and held it in 1 quarter. The position peaked at $326K in Q2 2016. 345 funds tracked by Wall St. Rank hold BHC as of Q3 2016.

Argentiere Capital reported no remaining Bausch Health position as of Q3 2016 after selling out during the quarter.
Argentiere Capital sold 16,200 Bausch Health shares in Q3 2016, an estimated $326K.
Argentiere Capital first reported a position in Bausch Health in Q2 2016 and held it in 1 quarter.
Argentiere Capital's Bausch Health position peaked at $326K in Q2 2016.
345 funds tracked by Wall St. Rank held Bausch Health as of Q3 2016.

Based on Argentiere Capital's 13F filing for Q3 2016, filed 9 Nov 2016.